Cardinal Health, US14149Y1082

Cardinal Health stock gets Wells Fargo target raised to $321

Published on 11/17/2026 at 12:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health stock gets a fresh analyst valuation marker from Wells Fargo. The bank kept its Overweight rating on the shares.

Wells Fargo lifts valuation view

  • The analyst increased its fiscal 2027 and 2028 earnings-per-share estimates by 3.2% and 4.1%.
  • Cardinal Health reported first-quarter fiscal 2027 adjusted earnings per share of 3.26 US dollars and raised its full-year outlook.
  • The bank cited strength across Cardinal Health's pharmaceutical and other segments.
Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Wells Fargo raised its price target for Cardinal Health to 321 US dollars from 277 US dollars while maintaining an Overweight rating, Investing.com reported on Tuesday, November 17, 2026. The move gives investors a new analyst reference after the healthcare services company delivered a strong first quarter of fiscal 2027 and increased its earnings outlook.

Analyst Stephen Baxter lifted his earnings-per-share estimates for Cardinal Health by 3.2% for fiscal 2027 to 12.96 US dollars and by 4.1% for fiscal 2028 to 14.43 US dollars. The report said the revisions reflect strength in the pharmaceutical and other segments.

Analyst view builds on earnings momentum

Cardinal Health reported first-quarter fiscal 2027 adjusted earnings per share of 3.26 US dollars, up 28% from the year-earlier period, according to the report. Revenue rose 5% to 67.5 billion US dollars, while the company lifted its adjusted earnings-per-share outlook for the full fiscal year to a range of 12.80 to 13.00 US dollars.

Wells Fargo based its new target on a 21-times multiple of calendar-year 2028 earnings per share, compared with 20 times previously. The report attributed the higher valuation view to fundamentals across Cardinal Health's businesses and potential upside to estimates. The company operates through pharmaceutical and medical businesses, including drug distribution, specialty services and medical products.

Cardinal Health stock traded at 259.00 euros on Lang & Schwarz at 12:41 CET on Tuesday, November 17.

Cardinal Health at a glance

  • Company: Cardinal Health, Inc.
  • ISIN: US14149Y1082
  • Ticker: CAH
  • Home exchange: NYSE
  • Sector: Healthcare
  • Industry: Medical distribution
  • Lang & Schwarz quote: 259.00 euros at 12:41 CET on November 17, 2026

Wells Fargo's action adds to a series of positive analyst revisions after the quarterly release, while the company's higher outlook places execution in pharmaceutical distribution and specialty services at the center of the investment case. The next major company-level focus is the delivery of the raised fiscal 2027 outlook.

The S&P 500 provides the relevant broad US equity-market context for Cardinal Health.

Investing.com reported the analyst action and the updated estimates. More news and analyses on Cardinal Health stock

Disclaimer...
en | US14149Y1082 | CARDINAL HEALTH | boerse | 70526414 | bgmi